Vial label design and print may vary between batches. Product specifications remain unchanged.
At a glance
Strength
10mg per vial
Form
Lyophilised powder
Purity
≥ 99% (HPLC)
CAS number
170851-70-4
Molecular weight
711.87 g/mol
Certificate of Analysis
Batch IP-10-15 · Prime Peptides UK
Storage
Follow supplier documentation and laboratory SOPs
Growth hormone secretagogues
Ipamorelin
Synthetic research peptide · 10mg · CAS 170851-70-4
£44.95 In stock · ready to shipper vial · £4.50 per mg
Ipamorelin 10mg is coming soon. It goes on sale as soon as its batch certificate is published - every vial we sell has a matching CoA.
Bank transferBitcoin Encrypted checkout · card details are never taken on this site
Multi-item discount. Add any 2 items for 4% off the whole order, 7% at 3, 10% at 4. Applied automatically at checkout.
Part of a stack. Ipamorelin is in the Growth & Performance Stack (CJC-1295 DAC 10mg · Ipamorelin 10mg · IGF-1 LR3 1mg).
Free
Free lab add-on. Bacteriostatic water is included with every peptide order at no extra cost.
Lab essentials tap to add to this order
RUOResearch Use Only. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher and accept responsibility for safe, lawful handling.
Same-day dispatch
Orders before 3:00 PM leave the same working day, tracked, in plain packaging. Free UK delivery over £200.
Secure payment
Bank transfer or Bitcoin over an encrypted checkout. No card details are stored or handled on this site.
Batch tested
Every batch is HPLC and mass spectrometry tested, and its certificate is published before it ships.
Ipamorelin 10mg≥99% HPLC · In stock
£44.95
Compound Overview
What Is Ipamorelin 10 mg?
Ipamorelin 10mg is an artificial peptide that is provided as a known amount of research material for laboratory or scientific research. This format is made for researchers in the UK who are looking into peptide chemistry, how peptides interact with receptors, and biological processes in a controlled lab environment. The 10 mg designation refers to the quantity of peptide material that will be supplied in the vial and should not be taken literally as a dosage for human or animal use. The product is being supplied solely for research and development purposes.
The pentapeptide ipamorelin has gained interest in the scientific field due to its interaction with receptors for growth hormone secretagogues in experimental situations. It is part of a larger family of peptides studied for their receptor-mediated signalling abilities. The use of Ipamorelin in laboratory studies has been conducted to investigate peptide-receptor binding and endocrine signalling and the behaviour of synthetic peptides under controlled conditions.
The Ipamorelin 10mg product format is lyophilised peptide material for analytical or experimental use in a 10mg format. This amount can be used for laboratory assays, stability studies, reference testing or other research projects where the volume of research material is dependent on the experimental protocol. The strength is only related to the amount supplied and does not mean that the product has been tested for greater biological activity or suitability for a specific application.
Technical Data
Ipamorelin Product Specifications
Technical Specification Sheet
IPAMORELIN · 10MG · RUO
Product name
Ipamorelin 10mg
Compound
Ipamorelin
Peptide type
Synthetic pentapeptide
Strength
10mg
Form
Lyophilised research material
Classification
Research compound
Testing
Laboratory testing documentation
COA
Batch-specific Certificate of Analysis with every batch
Intended use
Laboratory and scientific research only
Storage
Follow supplier documentation and laboratory SOPs
CAS Number
170851-70-4
Amino-Acid Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH2
Molecular Formula
C38H49N9O5
Molecular Weight
711.87 g/mol
Purity
≥99% by HPLC
Technical information should always be checked against the documentation supplied with the specific batch rather than relying solely on general peptide references.
The Science
Scientific Background of Ipamorelin
Ipamorelin is a new synthetic peptide developed from research into peptides that can interact with growth hormone receptors linked to growth hormone signals. It is a laboratory-synthesised peptide that is not found in nature and is used for experimental study. Because of its short amino-acid sequence, it has been used in investigations of the structure of peptides, their affinity for receptors and their mechanisms of action.
Research Context
In preclinical studies, Ipamorelin has been studied for its interaction with the growth hormone secretagogue receptors. These studies have focused on the activation of the receptor, downstream signalling and differences between synthetic peptide compounds. The study of the relationships between structure and receptor selectivity and experimental response is also of interest to researchers, as are examples of related peptides that have structural variations. Available evidence is largely preclinical or in the laboratory. The results of cell studies and animal experiments cannot be directly applied to humans nor presented as confirmed clinical results. Ipamorelin is not a registered drug and is currently only a research chemical.
Laboratory Focus
Areas Researchers Investigate
Neurological Pathways
Labs research ipamorelin for several scientific reasons. One aspect is related to the understanding of short synthetic peptides' recognition and binding to specific receptors. Such investigations could help expand general knowledge in peptide pharmacology and receptor biology and do not call for any conclusions regarding therapeutic applications.
Receptor Signalling
Endocrine signalling has also been the subject of other investigations in experimental models, such as the pathways activated after receptor activation. Scientists can also compare Ipamorelin to other peptides to study variations in molecular structure, receptor binding and signalling activity.
Laboratory Research
Other studies have focused on peptide stability, peptide degradation and analytical identification. These areas are relevant to peptide chemistry because they help us understand how synthetic compounds behave during storage and testing. While the scientific literature has extensively documented these research topics, they remain experimental. The scientific literature documents these research topics, but they still fall under the experimental category. They do not imply that Ipamorelin has proven results in human beings.
Product Format
Understanding the 10mg Research Format
10mg
Nominal Research Quantity
The 10mg label is the amount of Ipamorelin research material provided in the vial. It is not a dosage recommendation, nor does it suggest the use of the compound in the absence of a laboratory. Research peptides are available in various quantities due to the fact that the requirements of different research labs vary. A study that includes several analytical runs and repeated assays or multiple stages of experiments could require more material than a small proof-of-concept study. The quantity used for research may vary depending on the assay design, sample preparation, length of study and number of analyses planned.
When Ipamorelin 10 mg is used, researchers are provided with a specific amount of peptide material, which can be documented in their specific research protocols and inventory system. Selection should never be made based on biological potency assumptions, only on laboratory requirements.
Verification
Quality Testing, Purity and COA
When considering a research peptide, documentation and traceability are often as important as the peptide's name. Researchers usually seek analytical data to help identify the supplied material and obtain information on batch identification.
Batch-Specific CoA
If a Certificate of Analysis is available, it may include information regarding the batch, analytical methods employed and analytical results reported for that particular production batch. Peptide analysis is often accomplished using one or more techniques that are capable of evaluating the chromatographic properties of the peptide, such as high-performance liquid chromatography (HPLC), and other analytical techniques may be employed to help confirm its identity.
Identity vs Purity
Batch-specific documentation enables laboratories to maintain accurate records and compare materials between experiments. Responsible suppliers should not make unsupported purity claims, and they should provide information about the tests conducted on the lot that can be traced back to the actual batch. A researcher should examine the provided COA and related documents prior to using the peptide in a research study.
Handling
Storage and Laboratory Handling
Labelling & Traceability
Ipamorelin 10mg should be stored according to the instructions supplied with the specific batch and in line with the laboratory's standard operating procedures. Research materials are generally kept in their original, clearly labelled packaging until required for authorised experimental work.
Environmental Conditions
Laboratories should minimise unnecessary exposure to heat, moisture and prolonged light where applicable while maintaining appropriate inventory and contamination-control practices. Handling should take place using procedures suitable for peptide research materials, with records maintained for batch identification and storage conditions. If there is any uncertainty about storage requirements, the supplier's documentation should take precedence over general guidance.
Researchers looking to source Ipamorelin 10mg in the UK should focus on transparency rather than promotional claims. Important considerations include accurate product identification, batch-specific documentation, availability of a Certificate of Analysis, clear labelling and information about storage and handling.
A responsible peptide supplier should clearly identify the peptide supplied and which batch their paperwork applies to. Packaging should be robust and clearly labelled with the product identity and quantity, which should enable laboratories to keep traceable records.
Supplier transparency, documented testing and consistent product information are helpful to consider when evaluating research materials for a UK laboratory. These factors may be indicative of
good lab practice but should not be interpreted as meaning that a research peptide is an approved drug or safe for human use.
Analytical Records
Batch certificates for Ipamorelin
Every order ships with the CoA matched to its batch number, and the analytical records
are published here - open the certificate before you order, or cross-check the one in
your parcel.
'Ipamorelin 10 mg' means that the vial contains ten milligrams of Ipamorelin research material. The number describes the quantity supplied and is not a recommended dose or administration instruction.
Is Ipamorelin 10 mg intended for human use?
No. Ipamorelin 10mg is supplied for laboratory and scientific research purposes only. It is not intended for human consumption, self-administration or therapeutic use.
Why is Ipamorelin sold in different strengths?
Different quantities are available because laboratories have different experimental requirements. The amount selected may depend on study design, analytical work and the quantity of material needed for authorised research protocols.
What should researchers check on the Certificate of Analysis?
Researchers should review the batch number, product identification, analytical methods and reported results for the specific batch. The COA should correspond directly to the material being supplied.
How should Ipamorelin research material be stored?
Storage should follow the instructions supplied with the product and the laboratory's standard operating procedures. Original packaging, controlled storage conditions and accurate records help support material traceability.
What type of research has investigated Ipamorelin?
Ipamorelin has been studied for peptide-receptor interactions, growth hormone secretagogue receptor signalling and other questions in the field of preclinical studies. The majority of this evidence is based on laboratory or animal studies and not on the accepted clinical experience in humans.
PG
Medically & Scientifically Reviewed By
Dr. Priyanka Goel
Scientific & Medical Content Reviewer
Reviews research content against current published literature and UK regulatory guidance, ensuring compound information is accurate, referenced and presented for research use only.
The product Ipamorelin 10 mg is provided solely as a research compound used in laboratory or scientific investigations. It is not for human use, self-administration, or diagnostic or therapeutic use. Data on this page are intended to provide a description of the research product and its scientific context and should not be understood as advice on medicine or as proof of clinical approval.
